0MUD4KZ
Supplement Lower Spine Bursa and Ligament to No Qualifier with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | M Bursae and Ligaments |
| Operation | U Supplement |
| Body Part | D Lower Spine Bursa and Ligament |
| Approach | 4 Percutaneous Endoscopic |
| Device | K Nonautologous Tissue Substitute |
| Qualifier | Z No Qualifier |
Operation Definition
Putting in or on biological or synthetic material that physically reinforces and/or augments the function of a portion of a body part
Procedure Overview
Supplement procedures add biological or synthetic material to reinforce or augment a bursa or, much more commonly, a ligament that remains largely intact but needs additional structural support. A typical example is augmenting a partially torn ligament with a collagen patch, mesh, or allograft strip to bolster its strength without removing and fully replacing the native tissue.
This approach is chosen when a ligament has enough healthy tissue to preserve but is not strong enough on its own to withstand normal joint stress, often in cases of chronic laxity, partial tearing, or degenerative thinning. It is also used in some reconstructive techniques that combine native ligament preservation with graft augmentation, an increasingly common alternative to full replacement for certain knee and ankle ligament injuries. The added material integrates with the existing structure over time, aiming to restore joint stability while keeping as much of the patient's own tissue as possible.
Anatomy & Axis Detail
Lower Spine Bursa and Ligament
The lower spine bursa and ligament value applies to ligaments of the lumbar and sacral regions, including the interspinous, supraspinous, and posterior longitudinal ligaments that resist flexion forces and help maintain the lumbar lordosis. Supplement in this region reinforces a ligament that has become lax or degenerated, often in patients with chronic mechanical low back pain or early segmental instability, by adding graft material to the native structure rather than excising and substituting it entirely. This procedure is less common than bony fusion for lumbar instability but may be used as an adjunct when the ligamentous restraint itself is the primary deficiency. As with the upper spine, there is no laterality to report, so the operative note should specify the involved level.
Approach: Percutaneous Endoscopic
Percutaneous Endoscopic combines a puncture through skin or mucous membrane with insertion of an endoscope to visualize the procedure internally, as in laparoscopic cholecystectomy. It is distinguished from plain Percutaneous by the presence of scope-guided visualization, and from Via Natural or Artificial Opening Endoscopic by its route being a new puncture rather than an existing orifice or stoma.
Device: Nonautologous Tissue Substitute
Nonautologous Tissue Substitute refers to biologic material sourced from a donor or another species, such as an allograft or xenograft, used to replace a body part. It differs from Autologous Tissue Substitute by tissue origin outside the patient's own body, and from Synthetic Substitute by being biologic rather than manufactured material.
Coding & Documentation
Coders assign Supplement when the operative note describes reinforcing an existing bursa or ligament with graft, mesh, or other material while the native structure is left in place, not excised. Key language includes "augmented," "reinforced," or "buttressed with graft." The most frequent error is confusing this with Replacement - if the surgeon documents that the damaged ligament was removed before the new material was placed, Replacement is correct instead. Coders should also confirm the supplementing material is a recognized device or biologic value, since the device character of the procedure affects code selection.